Email Updates

Search form


End of AIDS

End of

Learn more

The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:

  • Deliver proven tools for immediate impacts.
  • Demonstrate and roll out new HIV prevention tools.
  • Develop long-term solutions to end the epidemic.

Learn more


  • May 24, 2017

    President Trump's 2018 budget request delivered to Congress yesterday would be a disaster for people living with HIV and for those at risk of HIV infection here in the US and around the world.

  • May 16, 2017

    This year on HIV Vaccine Awareness Day, our core message is simple: no end without a vaccine; no vaccine without funding.

  • May 15, 2017

    The Trump Administration, in expanding the Global Gag Rule, has implemented a policy change endangering the lives of millions of adolescent girls and young women living in countries supported by US global health development aid. AVAC and our partners in Africa will do all that we can to help ensure that lifesaving programs and information for women and girls continue.

  • May 11, 2017

    Our new issue of Px Wire offers an advocate’s guide to some new types of biomedical prevention trial designs. You’ll find a handy summary of long-acting PrEP trials, a lexicon of key terms for the "post-placebo era", and a handy illustration for looking smart while you explain "double-dummy double-blind".

Find Resources

AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.

What We Do

AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more

Px Methods

AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.